Clinical Research Directory
Browse clinical research sites, groups, and studies.
ePRO for the Timely Detection of Side Effects in Cancer Patients Undergoing CAR T Immunotherapy
Sponsor: Stiftung Swiss Tumor Institute
Summary
This study is designed as a feasibility study implementing electronic Patient Reported Outcomes (ePRO) in CAR T treatment for hematological malignancies, in order to describe AE reporting. ePRO assessments will be explored for their feasibility to engage in monitoring and management of CAR T-related toxicities as well as using these digital ePRO tools may improve both, its safety and accessibility.
Official title: ePRO for the Timely Detection of Side Effects in Cancer Patients Undergoing CAR T Immunotherapy: Feasibility Study (CARTePRO)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
11
Start Date
2022-03-21
Completion Date
2025-04-30
Last Updated
2024-04-19
Healthy Volunteers
No
Interventions
Consilium CareTM
This is an observational study using the Consilium CareTM smartphone ePRO application.
Locations (1)
Klinik für Hämatologie und Onkologie
Zurich, Switzerland